P01903 (DRA_HUMAN) Homo sapiens (Human)
HLA class II histocompatibility antigen, DR alpha chain UniProtKBInterProSTRINGInteractive Modelling
254 aa; Sequence (Fasta) ;
1 identical sequence: Homo sapiens: A0A0G2JMH6
Available Structures
135 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Crystal Structure of HLA-DR1 with CLIP102-120 |
Heteromer P01911; P04233; | 100 | 2×GOL; 1×FMT; | |||
| Human Leukocyte Antigen class II allotype DR1 presenting SARS-CoV-2 Spike peptide S511-530 |
Heteromer D7RIG0; P0DTC2; | 100 | 15×EDO; 2×SO4; 1×MES; | |||
| Human Leukocyte Antigen class II allotype DR1 presenting SARS-CoV-2 nsp14 peptide (orf1ab)6420-6434 |
Heteromer D7RIG0; P0DTD1; | 100 | 16×EDO; 4×SO4; | |||
| Crystal structure of DR11 presenting the RQ13 peptide |
Heteromer P01911; P04585; | 99.45 | 1×NAG; 2×NAG; 8×SO4; 3×NA; | |||
| Crystal structure of HLA-DR4 in complex with a human collagen type II peptide |
Heteromer A2BFX2; P02458; | 99.44 | 3×NAG; 4×GOL; | |||
| Human Leukocyte Antigen class II allotype DR1 presenting SARS-CoV-2 Membrane peptide M176-190 |
Heteromer D7RIG0; P0DTC5; | 100 | 1×MES; 1×EDO; | |||
| Human Leukocyte Antigen class II allotype DR1 presenting SARS-CoV-2 Spike peptide S761-775 |
Heteromer D7RIG0; P0DTC2; | 100 | 5×EDO; | |||
| Human Leukocyte Antigen class II allotype DR1 presenting SARS-CoV-2 Omicron (BA.1) Spike peptide S7… |
Heteromer D7RIG0; P0DTC2; | 100 | 7×EDO; 3×SO4; | |||
| TCR/HLA-DR2b/MBP-peptide complex |
Heteromer P01850; P01911; P02686; | 100 | 1×NAG; | |||
| MHC-II dynamics are maintained in HLA-DR allotypes to ensure catalyzed peptide exchange |
Heteromer A0A1V1IGJ9; P04233; | 100 | 9×EDO; 1×FLC; | |||
| Human Leukocyte Antigen class II allotype DR1 presenting SARS-CoV-2 nsp3 epitope (orf1ab)1350-1364 |
Heteromer D7RIG0; P0DTD1; | 100 | 1×EDO; 1×SIN; | |||
| Crystal structure of the MAM-MHC complex |
Heteromer P01911; P11133; Q48898; | 100 | 2×PO4; | |||
| COMPLEX OF THE HUMAN MHC CLASS II GLYCOPROTEIN HLA-DR1 AND THE BACTERIAL SUPERANTIGEN SEB |
Heteromer P01552; P01911; | 100 | ||||
| HLA-DR1 with CLIP102-120(M107W) |
Heteromer P01911; P04233; | 100 | ||||
| Crystal structure of HLA-DRB1*04:01 with modified alpha-enolase peptide 326-340 (arginine 327 to ci… |
Heteromer P01911; P06733; | 100 | 3×MPD; 1×URE; 1×PGE; | |||
| Human Leukocyte Antigen class II allotype DR1 presenting P11T->R modified influenza A virus haemagg… |
Heteromer P01911; P03437; | 100 | 6×SO4; 16×EDO; | |||
| Human Leukocyte Antigen class II allotype DR1 presenting SARS-CoV-2 Omicron (BA.1) Spike peptide S4… |
Heteromer D7RIG0; P0DTC2; | 100 | 30×EDO; 1×SO4; 1×DHL; | |||
| HLA-DR1 with the QAR Peptide |
Heteromer P01911; | 100 | 1×PEG; 4×EDO; 1×GOL; 1×SO4; | |||
| Human Leukocyte Antigen class II allotype DR1 presenting SARS-CoV-2 Spike peptide S486-505 |
Heteromer D7RIG0; P0DTC2; | 100 | 10×EDO; 1×DHL; | |||
| Crystal structure of HLA-DRB1*04:01 in complex with modified alpha-enolase peptide 26-40 with citru… |
Heteromer P01911; P06733; | 100 | ||||
| Structure of human MHC class II protein HLA-DR1 carrying an influenza hemagglutinin peptide partial… |
Heteromer P01911; | 99.44 | ||||
| Structure of HLA-DR1 with a bound peptide with non-optimal alanine in the P1 pocket |
Heteromer P01911; P04439; | 100 | ||||
| TCR interaction with peptide mimics of nickel offers structure insights to nickel contact allergy |
Heteromer B8YAC7; | 100 | 3×NAG; 3×IPA; | |||
| The structure of HLA-DRA, DRB3*0101 (DR52a) with bound platelet integrin peptide associated with fe… |
Heteromer P05106; P79483; | 100 | ||||
| immune receptor complex |
Heteromer P01911; P02675; | 100 | 3×NAG; 20×GOL; 1×NA; | |||
| Crystal Structure of the Complex of the MHC Class II Molecule HLA-DR1 (HA peptide 306-318) with the… |
Heteromer P01911; P0A0L5; | 100 | ||||
| HLA-DR1 in complex with a synthetic peptide (AAYSDQATPLLLSPR) |
Heteromer P01911; P27705; | 100 | ||||
| Crystal Structure of a Complex of a Human alpha/beta-T cell Receptor, Influenza HA Antigen Peptide,… |
Heteromer P01848; P01850; P01911; P03437; | 100 | 1×NAG; 2×NAG; | |||
| Crystal structure of DR11 presenting the gag293 epitope |
Heteromer P01911; P04585; | 100 | 1×NAG; 2×NAG; 5×SO4; 3×NA; 2×ACT; | |||
| HLA-DR1 complexed with a 16 residue HIV capsid peptide bound in a hairpin conformation |
Heteromer P01911; P0A0L5; P12495; | 100 | ||||
| X-RAY CRYSTAL STRUCTURE OF HLA-DR4 COMPLEXED WITH A PEPTIDE FROM HUMAN COLLAGEN II |
Heteromer P01552; P01911; P02458; | 100 | 1×NAG; | |||
| Crystal structure of HLA-DM bound to HLA-DR1 |
Heteromer P01911; P28067; P28068; | 99.44 | 1×NAG; | |||
| CRYSTAL STRUCTURE OF HLA-DR2 (DRA*0101,DRB1*1501) COMPLEXED WITH A PEPTIDE FROM HUMAN MYELIN BASIC … |
Heteromer P01911; P02686; | 100 | 2×NAG; | |||
| Crystal structure of HLA_DRB1*04:01 in complex with alpha-enolase peptide 26-40 |
Heteromer P01911; P06733; | 100 | ||||
| CRYSTAL STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN H IN COMPLEX WITH HUMAN MHC CLASS II |
Heteromer P01911; P0A0M0; Q03909; | 100 | 1×ZN; | |||
| CRYSTAL STRUCTURE OF A COMPLEX OF A HUMAN ALPHA/BETA-T CELL RECEPTOR, INFLUENZA HA ANTIGEN PEPTIDE,… |
Heteromer P01848; P01850; P01911; P03437; | 100 | 2×NAG; | |||
| Crystal Structure of the Complex of the MHC Class II Molecule HLA-DR1 (HA peptide 306-318) with the… |
Heteromer P01911; P0A0L5; | 100 | ||||
| Structure of the Epstein-Barr Virus gp42 Protein Bound to the MHC class II Receptor HLA-DR1 |
Heteromer P01911; P03205; P03437; | 100 | ||||
| HLA-DR1 with SGP Influenza Matrix Peptide |
Heteromer P01911; P05777; | 100 | 1×PEG; 4×EDO; 1×GOL; | |||
| Crystal Structure of the Complex of the MHC Class II Molecule HLA-DR1(HA peptide 306-318) with the … |
Heteromer P01911; P0A0L5; | 100 | ||||
| Crystal structure of DR1 presenting the RQ13 peptide |
Heteromer P01911; P04585; | 99.44 | 2×PEG; 1×NAG; | |||
| CRYSTAL STRUCTURE OF THE HUMAN CLASS II MHC PROTEIN HLA-DR1 COMPLEXED WITH AN INFLUENZA VIRUS PEPTI… |
Heteromer P01911; P04664; | 100 | 2×NAG; 4×NAG; | |||
| Mycoplasma arthritidis-derived mitogen complexed with class II MHC molecule HLA-DR1/HA complex in t… |
Heteromer P01911; Q48898; Q91LS8; | 100 | 2×PO4; | |||
| Crystal structure of an immune complex at pH 6.5 |
Heteromer P01911; P28067; P28068; | 99.44 | 3×NAG; | |||
| X-ray crystal structure of HLA-DRA1*0101/DRB5*0101 complexed with a peptide from Epstein Barr Virus… |
Heteromer P03198; Q30154; | 100 | 1×NAG; 1×NAG; | |||
| Cryo-EM structure of human invariant chain in complex with HLA-DR15 |
Heteromer P01911; P04233; | 100 | ||||
| Crystal structure of HLA-DRB1*04:01 with the alpha-enolase peptide 326-340 |
Heteromer P01911; P06733; | 100 | 1×MRD; 2×URE; 2×MPD; | |||
| Immune Receptor |
Heteromer P01911; P08670; | 100 | 1×NAG; 2×NAG; 8×EDO; 1×PGE; | |||
| Immune Receptor |
Heteromer P01911; P08670; | 100 | 1×NAG; 2×NAG; 1×EDO; | |||
| Human Leukocyte Antigen class II allotype DR1 presenting influenza A virus haemagglutinin (HA)306-3… |
Heteromer P01911; P03437; | 100 | 1×EPE; 13×EDO; 8×GOL; | |||
| MHC-II dynamics are maintained in HLA-DR allotypes to ensure catalyzed peptide exchange |
Heteromer A0A4E9DJJ3; P04233; | 100 | 6×EDO; | |||
| F11 TCR in complex with Human Leukocyte Antigen class II allotype DR1 presenting P11T->R modified i… |
Heteromer P01911; P03437; | 100 | 15×EDO; 2×P4G; | |||
| HLA-DRB1*1402 in complex with Vimentin59-71 |
Heteromer A0A0A1I7H6; P08670; | 100 | 1×NAG; 1×NAG; 4×EDO; 2×PGE; | |||
| STRUCTURAL BASIS FOR THE BINDING OF AN IMMUNODOMINANT PEPTIDE FROM MYELIN BASIC PROTEIN IN DIFFEREN… |
Heteromer P02686; Q30154; | 100 | 2×SO4; 1×GOL; | |||
| Crystal structure of HLA-DR1/TPI(23-37) complexed with staphylococcal enterotoxin C3 variant 3B2 (S… |
Heteromer P01911; P0A0L5; P60174; | 100 | ||||
| Immune Receptor |
Heteromer P01911; P16112; | 100 | 1×NAG; 2×NAG; 3×EDO; | |||
| HLA-DRB1*1402 in complex with Vimentin-64Cit59-71 |
Heteromer A0A0A1I7H6; P08670; | 100 | 2×NAG; | |||
| Immune Receptor |
Heteromer P01911; P08670; | 100 | 1×NAG; 2×NAG; 1×EDO; | |||
| HLA-DRB1 in complex with citrullinated Histone 2B peptide |
Heteromer P01911; Q8N257; | 100 | 2×NAG; 1×B3P; | |||
| Human class II MHC protein HLA-DR1 bound to a designed peptide related to influenza virus hemagglut… |
Heteromer P01911; P03437; P0A0L3; | 100 | ||||
| Immune Receptor |
Heteromer P01911; P08670; | 100 | 1×NAG; 2×NAG; | |||
| HLA-DR1 complexed with a 13 residue HIV capsid peptide |
Heteromer P01911; P0A0L5; P12495; | 100 | ||||
| Immune Receptor |
Heteromer P01911; P08670; | 100 | 3×NAG; 2×EDO; | |||
| Crystal Structure of the MHC Class II Molecule HLA-DR1 in Complex with the Fluorogenic Peptide, AcP… |
Heteromer A8CDU0; P01911; P0A0L5; | 100 | ||||
| immune receptor complex |
Heteromer P01911; P02675; | 100 | 2×NAG; 13×GOL; | |||
| T cell recognition of citrullinated alpha-enolase peptide presented by HLA-DR4 |
Heteromer P01911; P06733; | 100 | 1×NAG; 2×NAG; 2×ACT; 3×FMT; 2×GOL; | |||
| Immune Receptor |
Heteromer P01911; P08670; | 100 | 3×NAG; | |||
| Crystal structure of a complete ternary complex between TCR, superantigen, and peptide-MHC class II… |
Heteromer A2NTY6; P01738; P01911; Q48898; | 100 | ||||
| HLA-DR1 (DRA, DRB1 0101) HUMAN CLASS II HISTOCOMPATIBILITY PROTEIN (EXTRACELLULAR DOMAIN) COMPLEXED… |
Heteromer P01911; P04439; | 100 | ||||
| X-RAY CRYSTAL STRUCTURE OF HLA-DR4 COMPLEXED WITH DIPEPTIDE MIMETIC AND SEB |
Heteromer P01552; P01911; | 100 | ||||
| Crystal structure of HLA-DR4 bound to GP100 peptide |
Heteromer P01911; P40967; | 100 | ||||
| HLA-DR1 in complex with a synthetic peptide (AAYSDQATPLLLSPR) and the superantigen SEC3-3B2 |
Heteromer P01911; P0A0L5; P27705; | 100 | ||||
| TCR interaction with peptide mimics of nickel offers structure insight to nickel contact allergy |
Heteromer B8YAC7; | 100 | 1×NAG; | |||
| Structural basis for the recognition of mutant self by a tumor-specific, MHC class II-restricted T … |
Heteromer P01911; P60174; | 100 | 2×NA; | |||
| T cell recognition of citrullinated vimentin peptide presented by HLA-DR4 |
Heteromer P01911; P08670; | 100 | 2×NAG; 7×GOL; 6×SO4; 1×NAG; | |||
| HLA-DR1 bound with CLIP peptide |
Heteromer P01911; P04233; | 100 | ||||
| Structural basis for recognition of mutant self by a tumor-specific, MHC class II-restricted TCR |
Heteromer P01848; P01850; P01911; P60174; | 100 | ||||
| Crystal structure of F24 TCR -DR1-RQ13 peptide complex |
Heteromer A0A0B4J272; A0A5B9; P01911; P04585; | 100 | 1×NAG; | |||
| HLA-DR1 with GMF Influenza PB1 Peptide |
Heteromer P01911; | 100 | ||||
| Crystal structure of HLA-DRA*01:01/HLA-DRB1*04:01 in complex with c44H10 Fab |
Heteromer A0A1V1IGJ9; P04664; | 100 | 1×NAG; 10×SO4; 1×NAG; | |||
| HLA-DR1 mutant bN82A with covalently linked CLIP106-120(M107W) |
Heteromer P01911; | 100 | ||||
| CRYSTAL STRUCTURE OF A SUPERANTIGEN BOUND TO THE HIGH-AFFINITY, ZINC-DEPENDENT SITE ON MHC CLASS II |
Heteromer P02686; Q30154; Q8NKX2; | 100.0 | 1×ZN; | |||
| Crystal structure of the D227A variant of Staphylococcal enterotoxin A in complex with human MHC cl… |
Heteromer P01911; P0A0L2; | 100 | ||||
| Engineered peptide-specific binder in complex with HLA-DR1/CLIP |
Heteromer D7RIG0; P04233; Q48898; | 100 | 3×NAG; | |||
| Crystal structure of HLA DR52c |
Heteromer B8YAC7; Q05639; | 100 | 2×NAG; 1×SO4; | |||
| Structure of F11TCR in complex with DR1 MHC Class II presenting PKYVKQNTLKLAT |
Heteromer P01911; P03435; | 100 | 6×EDO; 1×SO4; 2×PEG; | |||
| HLA class II peptide flanking residues tune the immunogenicity of a human tumor-derived epitope |
Heteromer P01911; Q13641; | 100 | 16×EDO; 3×PO4; | |||
| Crystal Structure of Staphylococcal Enterotoxin I (SEI) in Complex with a Human MHC class II Molecu… |
Heteromer P01911; P04664; Q52T95; | 100 | 4×SO4; 1×EPE; 2×DIO; 1×ZN; | |||
| X-RAY CRYSTAL STRUCTURE OF HLA-DR4 COMPLEXED WITH PEPTIDOMIMETIC AND SEB |
Heteromer P01552; P01911; | 100 | ||||
| X-RAY CRYSTAL STRUCTURE OF HLA-DR4 COMPLEXED WITH PEPTIDE AND SEB |
Heteromer P01552; P01911; | 100 | 1×NAG; | |||
| HLA-DRB1 in complex with Histone 2B peptide |
Heteromer P01911; Q96A08; | 100 | 2×NAG; 1×B3P; | |||
| Structure of MHC class II molecule HLA-DR1 complexed with phosphopeptide MART-1 |
Heteromer P01911; Q16655; | 99.44 | ||||
| Crystal structure of CD4 mutant bound to HLA-DR1 |
Heteromer P01730; P01911; P03437; | 99.44 | 5×GOL; | |||
| Structure of HLA-DR15 with bound alpha3(135-145) peptide |
Heteromer P01911; | 100 | 1×NAG; 1×NAG; | |||
| MHC-II dynamics are maintained in HLA-DR allotypes to ensure catalyzed peptide exchange |
Heteromer D7RIG5; P04233; | 100 | 9×EDO; | |||
| HLA-DRB1 in complex with citrullinated LL37 peptide |
Heteromer P01911; P49913; | 100 | 2×NAG; | |||
| HLA-DR1 with covalently linked CLIP106-120 in reversed orientation |
Heteromer P01911; P04233; | 100 | 2×GOL; | |||
| Crystal structure of the ternary complex between human T cell receptor, staphylococcal enterotoxin … |
Heteromer P01848; P01850; P01911; P0A0M0; Q03909; | 100 | 4×GOL; 1×NA; | |||
| F54C HLA-DR1 bound with CLIP peptide |
Heteromer P01911; P04233; | 99.44 | ||||
| Crystal structure of DR15 presenting the RQ13 peptide |
Heteromer P01911; P04585; | 100 | 2×NAG; 1×PGE; 1×PO4; | |||
| Crystal structure of F24 TCR -DR11-RQ13 peptide complex |
Heteromer A0A0B4J272; A0A5B9; P01911; P04585; | 100 | 2×NAG; 3×MG; | |||
| Crystal structure of CD4 mutant bound to HLA-DR1 |
Heteromer P01730; P01911; P03437; | 99.44 | 1×GOL; | |||
| Crystal structure of F5 TCR -DR11-RQ13 peptide complex |
Heteromer A0A0B4J272; A0A0G2JMB4; P01911; P04585; | 100 | 2×NAG; 4×SO4; 2×CL; 1×MG; | |||
| Crystal Structure of HLA-DR1 with CLIP106-120, canonical peptide orientation |
Heteromer P01911; P04233; | 100 | ||||
| Crystal structure of F24 TCR -DR15-RQ13 peptide complex |
Heteromer A0A0B4J272; A0A5B9; P01911; P04585; | 100 | 1×NAG; 2×MG; 1×SO4; | |||
| Crystal structure of a human autoimmune TCR MS2-3C8 bound to MHC class II self-ligand MBP/HLA-DR4 |
Heteromer A0A5B9; P01848; P01911; | 100 | ||||
| Structural basis for recognition of mutant self by a tumor-specific, MHC class II-restricted TCR |
Heteromer P01848; P01850; P01911; P60174; | 100 | ||||
| Crystal structure of 3A6 TCR bound to MBP/HLA-DR2a |
Heteromer P01848; P01850; P02686; Q30154; | 100 | ||||
| HLA-DRB1 in complex with citrullinated LL37 peptide |
Heteromer P01911; P49913; | 100 | 2×NAG; | |||
| X-ray structure of the complex between staphylococcal enterotoxin B, T cell receptor and major hist… |
Heteromer A0A5B9; P01552; P01848; P01911; P03437; | 100 | ||||
| TCR complex |
Heteromer P01911; | 100 | 2×NAG; 2×SO4; | |||
| Crystal structure of humanized 44H10 Fab Version 22 in complex with HLA-DR (HLA-DRA*01:01/HLA-DRB1*… |
Heteromer A0A1V1IGJ9; | 100 | 2×NAG; 1×SO4; | |||
| Crystallographic structure of a rheumatoid arthritis MHC susceptibility allele, HLA-DR1 (DRB1*0101)… |
Heteromer P01911; P02458; | 89.89 | ||||
| HLA-DRB1*15:01 in complex with smith antigen |
Heteromer P01911; P63162; | 100 | 1×NAG; | |||
| TCR interaction with peptide mimics of nickel offers structural insights in nickel contact allergy |
Heteromer L7MTK9; L7MTL0; P79483; | 100 | ||||
| Structure of HLA-DR1 with bound alpha3(135-145) peptide |
Heteromer P01911; | 100 | 1×NAG; | |||
| Crystal structure of a complete ternary complex of T cell receptor, peptide-MHC and CD4 |
Heteromer A0A5B9; P01730; P01848; P01911; | 100 | ||||
| immune complex |
Heteromer P01308; P01911; | 100 | 1×NAG; | |||
| Crystal structure of Immune Receptor |
Heteromer P01911; P02458; | 100 | 3×NAG; 1×B3P; | |||
| HLA-DRB1 in complex with citrullinated fibrinogen peptide |
Heteromer P01911; P02675; | 100 | 2×NAG; | |||
| Crystal structure of HLA-DR4 in complex with a HSP70 peptide |
Heteromer A0A1V1IGJ9; P9WMJ9; | 100 | 1×NAG; 1×NAG; | |||
| HLA-DRB1 in complex with citrullinated Vimentin peptide |
Heteromer P01911; P08670; | 100 | 2×NAG; | |||
| HLA-DR1 with covalently linked CLIP106-120 in canonical orientation |
Heteromer P01911; P04233; | 100 | 4×GOL; | |||
| HLA-DRB1 in complex with citrullinated fibrinogen peptide |
Heteromer P01911; P02675; | 100 | 2×NAG; | |||
| Crystal structure of HLA-DR1/TPI(23-37, Thr28-->Ile mutant) complexed with staphylococcal enterotox… |
Heteromer P01911; P0A0L5; P60174; | 100 | ||||
| CRYSTAL STRUCTURE OF HLA-DR4 COMPLEX WITH PEPTIDOMIMETIC AND SEB |
Heteromer P01552; P01911; | 100 | ||||
| HLA-DRB1 in complex with Type II collagen peptide |
Heteromer P01911; P02458; | 100 | 1×NAG; 2×NAG; | |||
| immune receptor complex |
Heteromer P01911; P02675; | 100 | 1×NAG; 9×GOL; | |||
| Crystal Structure of HLA-DR1 with CLIP106-120, flipped peptide orientation |
Heteromer P01911; P04233; | 100 | ||||
| HLA-DRB1*1402 in complex with citrullinated fibrinogen peptide |
Heteromer A0A0A1I7H6; P02675; | 100 | 2×NAG; 1×B3P; | |||
| immune receptor complex |
Heteromer P01911; P02675; | 100.0 | 3×NAG; 4×GOL; | |||
| T cell recognition of citrullinated vimentin peptide presented by HLA-DR4 |
Heteromer P01911; P08670; | 100 | 1×NAG; 10×GOL; | |||
| THE STRUCTURE OF AN INTERMEDIATE IN CLASS II MHC MATURATION: CLIP BOUND TO HLA-DR3 |
Heteromer P01911; P04233; | 100 | 2×NAG; | |||
| immune receptor complex |
Heteromer P01911; P02675; | 100 | 3×NAG; 5×GOL; | |||
| immune receptor complex |
Heteromer P01911; P02675; | 100 | 3×NAG; 4×GOL; | |||
2 SWISS-MODEL models
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 8vrw.1.A | monomer | 0.81 | 100.00 | |||
| 7n6d.2.A | monomer | 0.63 | 19.88 | |||